ACS
TMO icon

Archford Capital Strategies’s Thermo Fisher Scientific TMO Stock Holding History

Archford Capital Strategies’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Sell
2,534
-23
-0.9% -$11K 0.13% 142
2026
Q1 		$1.26M Buy
2,557
+45
+2% +$24.4K 0.14% 144
2025
Q4 		$1.46M Sell
2,512
-209
-8% -$118K 0.17% 123
2025
Q3 		$1.32M Sell
2,721
-160
-6% -$74.5K 0.16% 133
2025
Q2 		$1.17M Buy
2,881
+144
+5% +$60.2K 0.15% 136
2025
Q1 		$1.36M Sell
2,737
-1,364
-33% -$739K 0.2% 122
2024
Q4 		$2.13M Buy
4,101
+80
+2% +$44K 0.32% 77
2024
Q3 		$2.43M Buy
4,021
+53
+1% +$31.4K 0.37% 68
2024
Q2 		$2.19M Buy
3,968
+2
+0.1% +$1.15K 0.36% 71
2024
Q1 		$2.31M Sell
3,966
-6
-0.2% -$3.37K 0.39% 67
2023
Q4 		$2.11M Buy
3,972
+545
+16% +$264K 0.39% 68
2023
Q3 		$1.73M Buy
3,427
+445
+15% +$237K 0.35% 70
2023
Q2 		$1.7M Buy
2,982
+387
+15% +$209K 0.32% 71
2023
Q1 		$1.5M Buy
2,595
+8
+0.3% +$4.51K 0.31% 74
2022
Q4 		$1.42M Buy
2,587
+35
+1% +$18.5K 0.33% 78
2022
Q3 		$1.29M Buy
2,552
+40
+2% +$22.4K 0.33% 78
2022
Q2 		$1.36M Sell
2,512
-15
-0.6% -$8.26K 0.34% 76
2022
Q1 		$1.48M Buy
2,527
+151
+6% +$86.7K 0.33% 75
2021
Q4 		$1.58M Sell
2,376
-46
-2% -$28.7K 0.36% 67
2021
Q3 		$1.38M Buy
2,422
+136
+6% +$74.6K 0.33% 73
2021
Q2 		$1.15M Sell
2,286
-1,097
-32% -$518K 0.29% 87
2021
Q1 		$1.67M Sell
3,383
-18
-0.5% -$8.59K 0.44% 55
2020
Q4 		$1.74M Buy
3,401
+29
+0.9% +$13.6K 0.4% 72
2020
Q3 		$1.49M Sell
3,372
-142
-4% -$58.7K 0.4% 76
2020
Q2 		$1.27M Sell
3,514
-17
-0.5% -$5.7K 0.38% 83
2020
Q1 		$1M Sell
3,531
-181
-5% -$57.1K 0.39% 77
2019
Q4 		$1.21M Sell
3,712
-151
-4% -$45.8K 0.42% 74
2019
Q3 		$1.13M Sell
3,863
-217
-5% -$62.1K 0.42% 70
2019
Q2 		$1.2M Sell
4,080
-503
-11% -$139K 0.44% 65
2019
Q1 		$1.25M Sell
4,583
-27
-0.6% -$6.72K 0.46% 60
2018
Q4 		$1.03M Buy
4,610
+43
+0.9% +$10.1K 0.41% 68
2018
Q3 		$1.11M Sell
4,567
-1,505
-25% -$346K 0.41% 71
2018
Q2 		$1.26M Buy
+6,072
New +$1.29M 0.44% 65
2018
Q1 		– Sell
-6,584
Closed -$1.25M – 707
2017
Q4 		$1.25M Sell
6,584
-64
-1% -$12.3K 0.47% 65
2017
Q3 		$1.26M Sell
6,648
-922
-12% -$167K 0.47% 72
2017
Q2 		$1.32M Sell
7,570
-157
-2% -$26.4K 0.52% 63
2017
Q1 		$1.19M Sell
7,727
-541
-7% -$82.7K 0.45% 67
2016
Q4 		$1.17M Sell
8,268
-680
-8% -$100K 0.49% 65
2016
Q3 		$1.42M Buy
8,948
+157
+2% +$24.2K 0.59% 51
2016
Q2 		$1.3M Buy
8,791
+30
+0.3% +$4.43K 0.68% 38
2016
Q1 		$1.24M Sell
8,761
-287
-3% -$38.5K 0.59% 52
2015
Q4 		$1.28M Buy
9,048
+571
+7% +$76.2K 0.58% 44
2015
Q3 		$1.04M Buy
8,477
+120
+1% +$15.6K 0.77% 31
2015
Q2 		$1.08M Buy
8,357
+374
+5% +$48.8K 0.77% 33
2015
Q1 		$1.07M Buy
7,983
+350
+5% +$45.1K 0.74% 42
2014
Q4 		$956K Buy
7,633
+13
+0.2% +$1.58K 0.7% 47
2014
Q3 		$927K Sell
7,620
-160
-2% -$19.5K 0.74% 30
2014
Q2 		$918K Sell
7,780
-110
-1% -$12.9K 0.71% 35
2014
Q1 		$949K Buy
+7,890
New +$938K 0.79% 25

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Archford Capital Strategies's TMO Position: Q2 2026 in Review

Archford Capital Strategies reduced its Thermo Fisher Scientific (TMO) stake by 0.9% in Q2 2026, selling an estimated $11K and leaving 2,534 shares worth $1.27M. The position accounts for 0.13% of the portfolio, ranked #142.

Archford Capital Strategies first reported a position in TMO in Q1 2014 and has held it in 49 quarters since. The position peaked at $2.43M in Q3 2024. 954 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Archford Capital Strategies held 2,534 shares of Thermo Fisher Scientific worth $1.27M as of Q2 2026.
  • Archford Capital Strategies sold 23 Thermo Fisher Scientific shares in Q2 2026, an estimated $11K.
  • Thermo Fisher Scientific made up 0.13% of Archford Capital Strategies's portfolio in Q2 2026, its #142 holding.
  • Archford Capital Strategies first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 49 quarters since.
  • Archford Capital Strategies's Thermo Fisher Scientific position peaked at $2.43M in Q3 2024.
  • 954 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.